Accrued Liabilities, Current in USD of Inhibrx, Inc. from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Inhibrx, Inc. quarterly Accrued Liabilities, Current history and change rate from Q4 2019 to Q1 2024.
  • Inhibrx, Inc. Accrued Liabilities, Current for the quarter ending 31 Mar 2024 was $51.3M, a 161% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Inhibrx, Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2024 $51.3M +$31.7M +161% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $43.3M +$26.1M +151% 31 Dec 2023 10-Q 09 May 2024
Q3 2023 $25.9M +$11.3M +77.4% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $19.6M +$7.08M +56.8% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $19.7M +$10.4M +112% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $17.2M +$7.6M +79% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $14.6M +$6.28M +75.4% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $12.5M +$5.49M +78.6% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $9.27M +$1.33M +16.7% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $9.62M -$3.74M -28% 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 $8.33M -$2.71M -24.6% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $6.98M 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $7.94M 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $13.4M +$8.53M +176% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $11M 30 Sep 2020 10-Q 13 Nov 2020
Q4 2019 $4.83M 31 Dec 2019 10-K 12 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.